-
Je něco špatně v tomto záznamu ?
Next-generation amplicon TRB locus sequencing can overcome limitations of flow-cytometric Vβ expression analysis and confirms clonality in all T-cell prolymphocytic leukemia cases
M. Kotrova, M. Novakova, S. Oberbeck, P. Mayer, A. Schrader, H. Knecht, O. Hrusak, M. Herling, M. Brüggemann,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 2003 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2012-06-01 do Před 1 rokem
Wiley Free Content
od 2003 do Před 1 rokem
PubMed
30414304
DOI
10.1002/cyto.a.23604
Knihovny.cz E-zdroje
- MeSH
- aktivace lymfocytů genetika MeSH
- dospělí MeSH
- imunofenotypizace metody MeSH
- lidé středního věku MeSH
- lidé MeSH
- průtoková cytometrie metody MeSH
- receptory antigenů T-buněk alfa-beta genetika MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- T-buněčná prolymfocytární leukemie genetika MeSH
- T-lymfocyty metabolismus MeSH
- vysoce účinné nukleotidové sekvenování metody MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
T-cell receptor (TCR) β repertoire analysis can distinguish monoclonal from polyclonal T-cell proliferations and crucially aid in the diagnosis of T-cell malignancies. TCR repertoire can be assessed either by flow cytometry (FCM), or by molecular genetic techniques. We compared the results of parallel analyses of Vβ expression by FCM and TRB rearrangements by DNA-based next-generation sequencing (NGS) in 80 diagnostic peripheral blood samples of patients with T-cell prolymphocytic leukemia (T-PLL) for (1) the diagnosis of clonality and (2) the assessment of dominant Vβ usage. FCM-based analysis of the surface expression was performed using the IOTest Beta Mark kit. The NGS-based analysis employed the multiplex Biomed-2 VB-JB primers. In all the samples, one or two clonal TRB rearrangements were detected by NGS. Although a dominant Vβ domain usage was detected by FCM in only 41/80 (51%) samples, clonality was suspected in all of them. In a total of 12 cases, the FCM missed the clone detected by NGS, despite theoretical coverage by the antibodies, the functionality of the rearrangement, and the expression of TCRαβ on the cell surface. Partly overlapping with those cases, FCM discovered predominant Vβ usage in the T-PLL population that differed from the one detected by NGS in 10 cases. Overall, the concordant NGS and FCM results were obtained on 61/80 (76%) of samples. We conclude that NGS-based TRB analysis can overcome certain limitations of FCM-based analysis by the identification of both productive and nonproductive rearrangements and by covering the whole Vβ spectrum. Currently available FCM analysis of Vβ expression lacks this breadth but has advantages, such as parallel immunophenotyping and a more accurate quantification of the Vβ usage. © 2018 International Society for Advancement of Cytometry.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045149
- 003
- CZ-PrNML
- 005
- 20200113143839.0
- 007
- ta
- 008
- 200109s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/cyto.a.23604 $2 doi
- 035 __
- $a (PubMed)30414304
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kotrova, Michaela $u Medical Department II, Unit for Hema-tological Diagnostics, University Hospital Schleswig-Holstein, Kiel, Germany.
- 245 10
- $a Next-generation amplicon TRB locus sequencing can overcome limitations of flow-cytometric Vβ expression analysis and confirms clonality in all T-cell prolymphocytic leukemia cases / $c M. Kotrova, M. Novakova, S. Oberbeck, P. Mayer, A. Schrader, H. Knecht, O. Hrusak, M. Herling, M. Brüggemann,
- 520 9_
- $a T-cell receptor (TCR) β repertoire analysis can distinguish monoclonal from polyclonal T-cell proliferations and crucially aid in the diagnosis of T-cell malignancies. TCR repertoire can be assessed either by flow cytometry (FCM), or by molecular genetic techniques. We compared the results of parallel analyses of Vβ expression by FCM and TRB rearrangements by DNA-based next-generation sequencing (NGS) in 80 diagnostic peripheral blood samples of patients with T-cell prolymphocytic leukemia (T-PLL) for (1) the diagnosis of clonality and (2) the assessment of dominant Vβ usage. FCM-based analysis of the surface expression was performed using the IOTest Beta Mark kit. The NGS-based analysis employed the multiplex Biomed-2 VB-JB primers. In all the samples, one or two clonal TRB rearrangements were detected by NGS. Although a dominant Vβ domain usage was detected by FCM in only 41/80 (51%) samples, clonality was suspected in all of them. In a total of 12 cases, the FCM missed the clone detected by NGS, despite theoretical coverage by the antibodies, the functionality of the rearrangement, and the expression of TCRαβ on the cell surface. Partly overlapping with those cases, FCM discovered predominant Vβ usage in the T-PLL population that differed from the one detected by NGS in 10 cases. Overall, the concordant NGS and FCM results were obtained on 61/80 (76%) of samples. We conclude that NGS-based TRB analysis can overcome certain limitations of FCM-based analysis by the identification of both productive and nonproductive rearrangements and by covering the whole Vβ spectrum. Currently available FCM analysis of Vβ expression lacks this breadth but has advantages, such as parallel immunophenotyping and a more accurate quantification of the Vβ usage. © 2018 International Society for Advancement of Cytometry.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a průtoková cytometrie $x metody $7 D005434
- 650 _2
- $a vysoce účinné nukleotidové sekvenování $x metody $7 D059014
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunofenotypizace $x metody $7 D016130
- 650 _2
- $a T-buněčná prolymfocytární leukemie $x genetika $7 D015461
- 650 _2
- $a aktivace lymfocytů $x genetika $7 D008213
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a receptory antigenů T-buněk alfa-beta $x genetika $7 D016693
- 650 _2
- $a T-lymfocyty $x metabolismus $7 D013601
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Novakova, Michaela $u Medical Department II, Unit for Hema-tological Diagnostics, University Hospital Schleswig-Holstein, Kiel, Germany. CLIP-Childhood Leukaemia Investigation Prague, Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
- 700 1_
- $a Oberbeck, Sebastian $u Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
- 700 1_
- $a Mayer, Petra $u Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
- 700 1_
- $a Schrader, Alexandra $u Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
- 700 1_
- $a Knecht, Henrik $u Medical Department II, Unit for Hema-tological Diagnostics, University Hospital Schleswig-Holstein, Kiel, Germany.
- 700 1_
- $a Hrusak, Ondrej $u CLIP-Childhood Leukaemia Investigation Prague, Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
- 700 1_
- $a Herling, Marco $u Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
- 700 1_
- $a Brüggemann, Monika $u Medical Department II, Unit for Hema-tological Diagnostics, University Hospital Schleswig-Holstein, Kiel, Germany.
- 773 0_
- $w MED00013935 $t Cytometry. Part A : the journal of the International Society for Analytical Cytology $x 1552-4930 $g Roč. 93, č. 11 (2018), s. 1118-1124
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30414304 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200113144211 $b ABA008
- 999 __
- $a ok $b bmc $g 1483418 $s 1083822
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 93 $c 11 $d 1118-1124 $e 20181110 $i 1552-4930 $m Cytometry. Part A $n Cytometry A $x MED00013935
- LZP __
- $a Pubmed-20200109